Novel ofloxacin-loaded microemulsion formulations for ocular delivery

Journal of Ocular Pharmacology and Therapeutics

Volumn 30, Issue 4, 2014, Pages 319-332

  Üstündag Okur, Neslihan ^a   Gökçe, Evren Homan ^a   Eǧrilmez, Sait ^a   Özer, Özgen ^a   Ertan, Gökhan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHITOSAN; CHITOSAN OLIGOSACCHARIDE LACTATE; LACTIC ACID DERIVATIVE; OFLOXACIN; OLEIC ACID; OLIGOSACCHARIDE; POLYSORBATE 80; SODIUM HYDROXIDE; UNCLASSIFIED DRUG; WATER; EMULSION; EYE DROPS; POLYSORBATE; SURFACTANT;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL KERATITIS; DRUG FORMULATION; DRUG STRUCTURE; ESCHERICHIA COLI; IN VITRO STUDY; MICROEMULSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RABBIT; STAPHYLOCOCCUS AUREUS; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; CORNEA; DRUG DELIVERY SYSTEM; DRUG EFFECTS; EMULSION; MALE; MEDICINAL CHEMISTRY; PARTICLE SIZE; PERMEABILITY; PH; PROCEDURES; SYNTHESIS; TOPICAL DRUG ADMINISTRATION; VISCOSITY;

ADMINISTRATION, TOPICAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CORNEA; DRUG DELIVERY SYSTEMS; EMULSIONS; ETHANOL; HYDROGEN-ION CONCENTRATION; MALE; OFLOXACIN; OLEIC ACID; OLIGOSACCHARIDES; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; PERMEABILITY; POLYSORBATES; RABBITS; SODIUM HYDROXIDE; SURFACE-ACTIVE AGENTS; VISCOSITY;

EID: 84899966180     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0114     Document Type: Article

References (59)

1. Shen, J., Wan, Y., Ping, Q., Xiao, Y., and Huang, X. Mu-coadhesive effect of thiolated PEG stearte and its modified NLC for ocular drug delivery. J. Control. Release 137:217-223, 2009.
2. Bourlais, C.L., et al. Ophthalmic drug delivery systems. Prog. Retin. Eye Res. 17:33-58, 1998.
3. Araújo, J., Gonzalez, E., Egea, M.A., Garcia, M.L., and Souto, E.B. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine 5:394-401, 2009.
4. Zhang, W., Prausnitz, M.R., and Edwards, A. Model of transient drug diffusion across cornea. J. Control. Release 99:241-258, 2004.
5. Gökçe, E.H., et al. Cyclosporine A-loaded solid lipid na-noparticles: ocular tolerance and in vivo drug release in rabbit eyes. Curr. Eye Res. 34:996-1003, 2009.
6. Onlen, Y., et al. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits. Microbiol. Res. 162:62-68, 2007.
7. Sanjay, N.R., et al. The effectiveness of a topical antibiotic irrigating solution in a model of staphylococcal keratitis after lamellar keratectomy. Am. J. Ophthalmol. 130:20-24, 2000.
8. Park, H.R., et al. Quenching of and flumequine fluorescence by divalent transition metal cations. Bull. Korean Chem. Soc. 27:2002-2009, 2006.
9. 2 catalytic treatment of ofloxacin in secondary treated effluents: evaluation of operational and kinetic parameters. Water Res. 44:5450-5460, 2010.
10. Fournier, B., Zhao, X., and Lu, T. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis. Antimicrob. Agents Chemother. 44:2160-2165, 2000.
11. Mizuuchi, K., Fisher, L.M., and O'Dea, M.H. DNA gyrase action involves the introduction of transient double-strand breaks into DNA. Proc. Natl. Acad. Sci. U S A. 77:1847-1851, 1980.
12. Araújo, J.E., Vega, E., Egea, M.A, Garcia, M.L., and Souto, E.B. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nano-spheres. Colloids Surf. B Biointerfaces 72:48-56, 2009.
13. Araújo, J., Gonzalez-Mira, E., Egea, M.A., Garcia, M.L., and Souto, E.B. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int. J. Pharm. 393:168-176, 2010.
14. Ali, Y., and Lehmussaari, K. Industrial perspective in ocular drug delivery. Adv. Drug Deliv. Rev. 58:1258-1268, 2006.
15. Anumolu, S.S., Singh, Y., Gao, D., Stein, S., and Sinko, P.J. Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response. J. Control. Release 137:152-159, 2009.
16. Agnihotri, S.M., and Vavia, P.R. Diclofenac-loaded bio-polymeric nanosuspensions for ophthalmic application. Nanomedicine 5:90-95, 2009.
17. Fuente, M., et al. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv. Drug Deliv. Rev. 62:100-117, 2010.
18. Chen, H., et al. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int. J. Pharm. 315:52-58, 2006.
19. Yuan, Y., Li, S., Mo, F., and Zhong, D. Investigation of microemulsion system for transdermal delivery of melex-icam. Int. J. Pharm. 321:117-123, 2006.
20. Üstündag Okur, N., Apaydin, Sx., Karabay Yavaxsoglu, Ü., Yavaxsoglu, A., and Karasulu, H.Y. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. Int. J. Pharm. 416:136-144, 2011.
21. Sahoo, S.K., Dilnawaz, F., and Krishnakumar, S. Nano-tecnology in ocular drug delivery. Drug Discov. Today 13:144-151, 2008.
22. Gan, L., Gan, Y., Zhu, C., Zhang, X., and Zhu, J. Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results. Int. J. Pharm. 365:143-149, 2009.
23. Lawrence, M.J., and Rees, G.D. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45:89-121, 2000.
24. Vandamme, T.H. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog. Retin. Eye Res. 21:15-34, 2002.
25. Ege, M.A., Karasulu, H.Y., and Güneri, T. Triangle Phase Diagram Analysis Software. Presented at: The 4th International Postgraduate Research Symposium on Pharmaceutics, I-stanbul, Turkey. Vol. 46, p. 36; 2004.
26. Tsai, Y.H., Lee, K.F., Huang, Y.B., Huang, C.T., and Wu, P.C. In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system, Int. J. Pharm. 388:252-262, 2010.
27. Fang, L., Numajiri, S., Kobayashi, D., and Morimoto, Y. The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid. Int. J. Pharm. 262:13-22, 2003.
28. Yue, Y., San-Ming, L., Pan, D., and Da-Fang, Z. Physi-cochemical properties and evaluation of microemulsion systems for transdermal delivery of meloxicam. Chem. Res. Chin. Univ. 23:81-86, 2007.
29. Kang, B.K., et al. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of antitumor activity in vitro and in vivo. Int. J. Pharm. 286:147-156, 2004.
30. Karasulu, H.Y. Microemulsions as novel drug carriers: the formation, stability, applications and toxicity. Expert Opin. Drug Deliv. 5:119-135, 2008.
31. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI Document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
32. Qi, L., Xu, Z., Jiang, X., Hu, C., and Zou, X. Preparation and antibacterial activity of chitosan nanoparticles. Car-bohydr. Res. 339:2693-2700, 2004.
33. Sensoy, D., et al. Bioadhesive sulfacetamide sodium mi-crospheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model. Eur. J. Pharm. Biopharm. 72:487-495, 2009.
34. Marquart, M.E. Animal models of bacterial keratitis. J. Biomed. Biotech. article ID 680642:1-12, 2011.
35. Baeyens, V., et al. Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs. J. Control. Release 85:163-168, 2002.
36. Rautio, J., Nevalainen, T., Taipale, H., Vepsalainen, J., Gynther, J., Laine, K., and Jarvinen, T. Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation. Eur. J. Pharm. Sci. 11:157-163, 2000.
37. Hapeshi, E., et al. Sonochemical degradation of ofloxacin in aqueous solutions. Water Sci. Technol. 61:3141-3146, 2010.
38. Okonogi, S., Oguchi, T., Yonemochi, E., Puttipipatkhachorn, S., and Yamamoto, K. Improved dissolution of ofloxacin via solid dispersion. Int. J. Pharm. 156:175-180, 1997.
39. Al-Omar, M.A. Ofloxacin. In: Harry, G., ed. Profiles of Drug Substances, Excipients, and Related Methodology. Vol. 34. Burlington, VT: Academic Press; 2009; p. 265-298.
40. Zimmer, A.K., Maincent, P., Thouvenot, P., and Kreuter, J. Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nano-particles. Int. J. Pharm. 110:211-222, 1994.
41. Taniguchi, K., Itakura, K., Morisaki, K., and Hayashi, S. Effects of tween 80 and liposomes on the corneal permeability of anti-inflammatory steroids. J. Pharmacobiodyn. 11:685-693, 1988.
42. Fialho, S.L., and da Silva-Cunha, A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin. Exp. Ophthalmol. 32:626-632, 2004.
43. Kogan, A., and Garti, N. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 126:369-385, 2006.
44. Bodor, N., and Buchwald, P. Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. Am. Assoc. Pharm. Sci. 7:820-833, 2005.
45. Mehnert, W., and Mäder, K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47:165-196, 2001.
46. Warisnoicharoen, W., Lansley, A.B., and Lawrence, M.J. Nonionic oil-in-water microemulsions: the effect of oil type on phase behavior. Int. J. Pharm. 198:7-27, 2000.
47. Mehta, S.K., and Kaur, G. Microemulsions: thermody-namic and dynamic properties thermodynamics. In: Tada-shi, M., ed. Thermodynamics. Shanghai: InTech; 2011; p. 381-406.
48. Cho, H.J., et al. Development of udenafil-loaded micro-emulsions for intranasal delivery: in vitro and in vivo evaluations. Int. J. Pharm. 423:153-160, 2012.
49. Peng, Y., et al. Preparation and antimicrobial activity of hydroxypropyl chitosan. Carbohydr. Res. 340:1846-1851, 2005.
50. Zignani, M., Tabatabay, C., and Gurny, R. Topical semisolid drug delivery: kinetics and tolerance of ophthalmic hydrogels. Adv. Drug Deliv. Rev. 16:51-69, 1995.
51. Van Der Bijl, P., Engelbrecht, A.H., Van Eyk, A.D., and Meyer, D. Comparative permeability of human and rabbit corneas to cyclosporin and tritiated water. J. Ocul. Pharmacol. Ther. 18:419-427, 2002.
52. Naveh, N., Muchtar, S., and Benita, S. Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged hypotensive effect in rabbits. J. Ocul. Pharmacol. Ther. 10:509-520, 1994.
53. Kaufman, H.E., Baron, B.A., and McDonald, M.B. The Cornea. New York: Churchill Livingstone; 1988; p. 217-247.
54. Rao, S.N., et al. The effectiveness of a topical antibiotic irrigating solution in a model of staphylococcal keratitis after lamellar keratoctemy. Am. J. Ophthalmol. 130:20-24, 2000.
55. Lukyanov, A.N., and Torchillin, V.P. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv. Drug Deliv. Rev. 56:1273-1289, 2004.
56. Rahul, N., Badivaddin, M.T., Sevukarajan, M., Sakeena, P.S., and Jeyachitra, B. Development and characterization of ofloxacin microemulsions for ocular application. Int. J. Pharm. Sci. 2:43-49, 2011.
57. Yamaguchi, M., et al. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug difluprednate. Int. J. Pharm. 301:121-128, 2005.
58. Alany, R.G., Tucker, I.G., Davies, N.M., and Rades, T. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev. Ind. Pharm. 27:31-38, 2001.
59. Ammar, H.O., Salama, H.A., Ghorab, M., and Mahmoud, A.A. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSci-Tech 10:808-819, 2009.